Binimetinib Impurity 18 | CAS 918321-31-0 - Request Quote
Binimetinib Impurity 18
| SZ CAT No: | SZ-B053034 |
| CAS No | 918321-31-0 |
| Mol.F. | C7H6FN3O4 |
| Mol.Wt. | 215.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Binimetinib Impurity 18 is chemically 2,4-Diamino-3-fluoro-5-nitrobenzoic acid. Binimetinib Impurity 18 is supplied with detailed characterization data compliant with regulatory guideline. Binimetinib Impurity 18 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Binimetinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 918321-31-0
Purchase 918321-31-0
Order 918321-31-0
Enquire 918321-31-0
price of 918321-31-0
918321-31-0 Supplier
918321-31-0 Manufacturer
918321-31-0 Exporter
buy high quality Binimetinib Impurity 18
Purchase Binimetinib Impurity 18
Binimetinib Impurity 18 suppliers
Binimetinib Impurity 18 manufacturers
Binimetinib Impurity 18 price
Order Binimetinib Impurity 18
Enquire Binimetinib Impurity 18
Binimetinib Impurity 18 cost
Binimetinib Impurity 18 Supplier
Binimetinib Impurity 18 Distributor
Binimetinib Impurity 18 for Method Validation
Binimetinib Reference Standard
Binimetinib Impurity 18 for ANDA Filing
Binimetinib Impurity 18 for Forced Degradation Studies
Binimetinib Impurity 18 Identification Standards
Binimetinib Impurity 18 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


